Global AI In Oncology For Analytical Solutions Market Size, Trends & Growth Opportunity, By Component (Data Licensing Services, Software Solutions, Analytics and Other Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Kidney Cancer, Non-Hodgkin Lymphoma, Bladder Cancer), By Region and Forecast till 2030.
Global AI In Oncology For Analytical Solutions Market.
The global AI In Oncology For Analytical Solutions market was valued at USD 880.3 million in 2022 which expected to reach USD 7430.3 million by 2030 at a CAGR 30.54% from 2023-2030.
The rising prevalence of cancer is driving the market. This is due to the fact that the number of cases is rapidly increasing worldwide. According to WHO, it is a leading cause of death worldwide, accounting for approximately 10 million deaths in 2020 alone, accounting for nearly one-sixth of all deaths. According to the World Health Organization, one-third of cancer-related deaths can be attributed to factors such as tobacco use, a high BMI, alcohol consumption, insufficient fruit and vegetable consumption, and a lack of physical activity. Cancer-causing infections, such as human papillomavirus (HPV) and hepatitis, account for approximately 30% of all cases in low- and middle-income countries.
Impact of COVID-19
The market response to the COVID-19 pandemic has been mixed. On the one hand, the pandemic has highlighted the importance of technology in healthcare, particularly AI-powered applications. The pandemic, on the other hand, has disrupted the healthcare system, including cancer care, affecting the adoption and implementation of AI in oncology. One of the most significant consequences of the pandemic has been a shift towards telemedicine and remote care. As a result, there has been an increase in the use of AI-powered telemedicine tools for disease diagnosis and treatment planning, as well as remote patient monitoring.
Market Segmentation
The Global AI in Oncology for Analytical Solutions Market is segmented into Component, Cancer Type. By Component such as Data Licensing Services, Software Solutions, Analytics and Other Services. Further, market is segmented into By Cancer Type such as Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Kidney Cancer, Non-Hodgkin Lymphoma, Bladder Cancer.
Regional Analysis
Global AI in Oncology for Analytical Solutions Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the market. The presence of digital infrastructure and favorable government policies are attributed to the growth. The region's adoption of oncology services is expected to increase due to rising government reimbursements. Furthermore, regional governments are increasing their spending on digital healthcare, which is expected to improve the IT infrastructure required to provide AI solutions to patients. For example, a study conducted by the Lancet Digital Health stated that if 60% of the US population undergoes screening colonoscopy, using AI for screening could prevent 7,194 cases of colorectal cancer and 2,089 colorectal cancer-related deaths annually, while also saving USD 290 million per year.
Key Players
Various key players are listed in this report such Azra AI, IBM, Siemens Healthineers, Intel, GE Healthcare, NVIDIA, Digital Diagnostics Inc., Concert.AI, Median Technologies.
Market Taxonomy
By Component
• Data Licensing Services
o Payers
o Providers
o Pharmaceuticals
• Software Solutions
o Payers
o Providers
o Pharmaceuticals
• Analytics and Other Services
o Payers
o Providers
o Pharmaceuticals
By Cancer Type
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Tumor
• Kidney Cancer
• Non-Hodgkin Lymphoma
• Bladder Cancer
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global AI In Oncology For Analytical Solutions Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global AI In Oncology For Analytical Solutions Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global AI In Oncology For Analytical Solutions Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global AI In Oncology For Analytical Solutions Market, By Component
5.1 Y-o-Y Growth Comparison, By Component
5.2 Global AI In Oncology For Analytical Solutions Market Share Analysis, By Component
5.3 Global AI In Oncology For Analytical Solutions Market Size and Forecast, By Component
5.3.1 Data Licensing Services
5.3.1.1 Payers
5.3.1.2 Providers
5.3.1.3 Pharmaceuticals
5.3.2 Software Solutions
5.3.2.1 Payers
5.3.2.2 Providers
5.3.2.3 Pharmaceuticals
5.3.3 Analytics and Other Services
5.3.3.1 Payers
5.3.3.2 Providers
5.3.3.3 Pharmaceuticals
6 Global AI In Oncology For Analytical Solutions Market, By Cancer Type
6.1 Y-o-Y Growth Comparison, By Cancer Type
6.2 Global AI In Oncology For Analytical Solutions Market Share Analysis, By Cancer Type
6.3 Global AI In Oncology For Analytical Solutions Market Size and Forecast, By Cancer Type
6.3. 1 Breast Cancer
6.3.2 Lung Cancer
6.3.3 Prostate Cancer
6.3.4 Colorectal Cancer
6.3.5 Brain Tumor
6.3.6 Kidney Cancer
6.3.7 Non-Hodgkin Lymphoma
6.3.8 Bladder Cancer
7 Global AI In Oncology For Analytical Solutions Market, By Region
7.1 Global AI In Oncology For Analytical Solutions Market Share Analysis, By Region
7.2 Global AI In Oncology For Analytical Solutions Market Share Analysis, By Region
7.3 Global AI In Oncology For Analytical Solutions Market Size and Forecast, By Region
8 North America AI In Oncology For Analytical Solutions Market Analysis and Forecast (2023-2030)
8.1 Introduction
8.2 North America AI In Oncology For Analytical Solutions Market Share Analysis, By Component
8.3 North America AI In Oncology For Analytical Solutions Market Size and Forecast, By Cancer Type
8.4 North America AI In Oncology For Analytical Solutions Market Size and Forecast, By Country
8.5.1 U.S.
8.6.2 Canada
8.7.3 Mexico
9 Europe AI In Oncology For Analytical Solutions Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 Europe AI In Oncology For Analytical Solutions Market Share Analysis, By Component
9.3 Europe AI In Oncology For Analytical Solutions Market Size and Forecast, By Cancer Type
9.4 Europe AI In Oncology For Analytical Solutions Market Size and Forecast, By Country
9.5.1 Germany
9.6.2 France
9.7.3 UK
9.8.4. Rest of Europe
10 Asia Pacific AI In Oncology For Analytical Solutions Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Asia Pacific AI In Oncology For Analytical Solutions Market Share Analysis, By Component
10.3 Asia Pacific AI In Oncology For Analytical Solutions Market Size and Forecast, By Cancer Type
10.4 Asia Pacific AI In Oncology For Analytical Solutions Market Size and Forecast, By Country
10.5.1 China
10.6.2 Japan
10.7.3 India
10.8.4. Rest of Asia Pacific
11 Latin America AI In Oncology For Analytical Solutions Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Latin America AI In Oncology For Analytical Solutions Market Share Analysis, By Component
11.3 Latin America AI In Oncology For Analytical Solutions Market Size and Forecast, By Cancer Type
11.4 Latin America AI In Oncology For Analytical Solutions Market Size and Forecast, Country
11.5.1. Brazil
11.6.2. Rest of Latin America
12 Middle East AI In Oncology For Analytical Solutions Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Middle East AI In Oncology For Analytical Solutions Market Share Analysis, By Component
12.3 Middle East AI In Oncology For Analytical Solutions Market Size and Forecast, By Cancer Type
12.4 Middle East AI In Oncology For Analytical Solutions Market Size and Forecast, By Country
12.5.1. Saudi Arabia
12.6.2. UAE
12.7.3. Egypt
12.8.4. Kuwait
12.9.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Azra AI
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. IBM
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Siemens Healthineers
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Intel
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 GE Healthcare
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 NVIDIA
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Digital Diagnostics Inc.
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Concert.AI
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Median Technologies
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
